WINDLAS BIOTECH
|
WINDLAS BIOTECH Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹6.41 Cr | ₹6.41 Cr |
Equity - Authorised | ₹54 Cr | ₹54 Cr | ₹54 Cr | ₹54 Cr | ₹6.50 Cr |
Equity - Issued | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹6.41 Cr | ₹6.41 Cr |
Equity Paid Up | ₹10 Cr | ₹10 Cr | ₹11 Cr | ₹6.41 Cr | ₹6.41 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹4.89 Cr | ₹2.82 Cr | ₹1.81 Cr | - | - |
Total Reserves | ₹435 Cr | ₹389 Cr | ₹382 Cr | ₹193 Cr | ₹203 Cr |
Securities Premium | ₹195 Cr | ₹199 Cr | ₹227 Cr | ₹75 Cr | ₹75 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹226 Cr | ₹176 Cr | ₹142 Cr | ₹104 Cr | ₹114 Cr |
General Reserves | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Other Reserves | ₹0.46 Cr | ₹0.40 Cr | ₹-0.01 Cr | ₹0.00 Cr | - |
Reserve excluding Revaluation Reserve | ₹435 Cr | ₹389 Cr | ₹382 Cr | ₹193 Cr | ₹203 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹450 Cr | ₹402 Cr | ₹395 Cr | ₹199 Cr | ₹210 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | ₹0.11 Cr | ₹0.44 Cr | ₹0.83 Cr | ₹1.21 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹0.11 Cr | ₹0.44 Cr | - | ₹0.70 Cr | ₹4.56 Cr |
Term Loans - Institutions | - | - | ₹0.81 Cr | ₹1.17 Cr | ₹1.82 Cr |
Other Secured | ₹-0.11 Cr | ₹-0.34 Cr | ₹-0.36 Cr | ₹-1.04 Cr | ₹-5.16 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr | ₹-0.66 Cr |
Deferred Tax Assets | ₹3.32 Cr | ₹3.65 Cr | ₹3.07 Cr | ₹1.32 Cr | ₹2.70 Cr |
Deferred Tax Liability | ₹2.75 Cr | ₹1.63 Cr | ₹1.04 Cr | ₹2.01 Cr | ₹2.04 Cr |
Other Long Term Liabilities | ₹2.20 Cr | ₹3.34 Cr | ₹0.24 Cr | ₹0.70 Cr | ₹1.13 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹2.32 Cr | ₹2.02 Cr | ₹1.57 Cr | ₹1.37 Cr | ₹1.19 Cr |
Total Non-Current Liabilities | ₹3.95 Cr | ₹3.44 Cr | ₹0.21 Cr | ₹3.59 Cr | ₹2.88 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹132 Cr | ₹88 Cr | ₹63 Cr | ₹40 Cr | ₹83 Cr |
Sundry Creditors | ₹132 Cr | ₹88 Cr | ₹63 Cr | ₹40 Cr | ₹83 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹40 Cr | ₹32 Cr | ₹25 Cr | ₹24 Cr | ₹21 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹2.14 Cr | ₹2.01 Cr | ₹0.73 Cr | ₹1.48 Cr | ₹0.71 Cr |
Interest Accrued But Not Due | - | ₹0.00 Cr | ₹0.00 Cr | ₹0.01 Cr | ₹0.08 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹37 Cr | ₹30 Cr | ₹24 Cr | ₹22 Cr | ₹20 Cr |
Short Term Borrowings | - | - | ₹5.31 Cr | ₹29 Cr | ₹21 Cr |
Secured ST Loans repayable on Demands | - | - | ₹5.31 Cr | ₹29 Cr | ₹21 Cr |
Working Capital Loans- Sec | - | - | ₹5.31 Cr | ₹9.50 Cr | ₹21 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | ₹-5.31 Cr | ₹-9.50 Cr | ₹-21 Cr |
Short Term Provisions | ₹0.73 Cr | ₹1.04 Cr | ₹0.33 Cr | ₹0.28 Cr | ₹0.41 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | ₹0.59 Cr | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.73 Cr | ₹0.45 Cr | ₹0.33 Cr | ₹0.28 Cr | ₹0.41 Cr |
Total Current Liabilities | ₹172 Cr | ₹121 Cr | ₹94 Cr | ₹93 Cr | ₹125 Cr |
Total Liabilities | ₹626 Cr | ₹527 Cr | ₹489 Cr | ₹296 Cr | ₹338 Cr |
ASSETS | |||||
Gross Block | ₹275 Cr | ₹194 Cr | ₹164 Cr | ₹184 Cr | ₹79 Cr |
Less: Accumulated Depreciation | ₹96 Cr | ₹85 Cr | ₹73 Cr | ₹88 Cr | ₹9.09 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹179 Cr | ₹109 Cr | ₹91 Cr | ₹96 Cr | ₹70 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹5.71 Cr | ₹14 Cr | ₹7.58 Cr | ₹0.04 Cr | - |
Non Current Investments | - | - | - | - | ₹94 Cr |
Long Term Investment | - | - | - | - | ₹94 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | ₹94 Cr |
Long Term Loans & Advances | ₹7.54 Cr | ₹43 Cr | ₹5.39 Cr | ₹5.84 Cr | ₹5.40 Cr |
Other Non Current Assets | ₹2.05 Cr | ₹5.92 Cr | ₹2.73 Cr | - | ₹0.13 Cr |
Total Non-Current Assets | ₹194 Cr | ₹173 Cr | ₹107 Cr | ₹102 Cr | ₹170 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹173 Cr | ₹107 Cr | ₹65 Cr | ₹23 Cr | ₹22 Cr |
Quoted | ₹173 Cr | ₹107 Cr | ₹65 Cr | ₹23 Cr | ₹22 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹62 Cr | ₹75 Cr | ₹59 Cr | ₹41 Cr | ₹49 Cr |
Raw Materials | ₹37 Cr | ₹38 Cr | ₹35 Cr | ₹25 Cr | ₹31 Cr |
Work-in Progress | ₹3.65 Cr | ₹18 Cr | ₹6.64 Cr | ₹8.55 Cr | ₹4.10 Cr |
Finished Goods | ₹13 Cr | ₹17 Cr | ₹10 Cr | ₹6.44 Cr | ₹13 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹0.19 Cr | ₹1.54 Cr | ₹4.07 Cr | ₹1.50 Cr | ₹0.91 Cr |
Other Inventory | ₹8.82 Cr | ₹0.26 Cr | ₹2.66 Cr | - | - |
Sundry Debtors | ₹136 Cr | ₹117 Cr | ₹111 Cr | ₹79 Cr | ₹64 Cr |
Debtors more than Six months | ₹4.23 Cr | ₹4.16 Cr | ₹2.31 Cr | ₹1.22 Cr | - |
Debtors Others | ₹136 Cr | ₹116 Cr | ₹110 Cr | ₹79 Cr | ₹65 Cr |
Cash and Bank | ₹31 Cr | ₹25 Cr | ₹114 Cr | ₹31 Cr | ₹18 Cr |
Cash in hand | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.24 Cr | ₹0.16 Cr |
Balances at Bank | ₹31 Cr | ₹25 Cr | ₹114 Cr | ₹31 Cr | ₹18 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1.65 Cr | ₹1.31 Cr | ₹3.17 Cr | ₹2.51 Cr | ₹0.46 Cr |
Interest accrued on Investments | ₹0.67 Cr | ₹0.44 Cr | ₹1.64 Cr | ₹0.13 Cr | ₹0.06 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.98 Cr | ₹0.87 Cr | ₹0.95 Cr | ₹1.11 Cr | ₹0.40 Cr |
Other current_assets | - | - | ₹0.57 Cr | ₹1.27 Cr | - |
Short Term Loans and Advances | ₹27 Cr | ₹29 Cr | ₹30 Cr | ₹17 Cr | ₹14 Cr |
Advances recoverable in cash or in kind | ₹1.07 Cr | ₹1.67 Cr | ₹2.98 Cr | ₹1.65 Cr | ₹0.89 Cr |
Advance income tax and TDS | ₹0.69 Cr | - | ₹4.10 Cr | ₹3.97 Cr | ₹0.90 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹25 Cr | ₹27 Cr | ₹23 Cr | ₹11 Cr | ₹12 Cr |
Total Current Assets | ₹431 Cr | ₹354 Cr | ₹382 Cr | ₹194 Cr | ₹168 Cr |
Net Current Assets (Including Current Investments) | ₹260 Cr | ₹232 Cr | ₹288 Cr | ₹101 Cr | ₹43 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹626 Cr | ₹527 Cr | ₹489 Cr | ₹296 Cr | ₹338 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹0.11 Cr | ₹0.44 Cr | ₹6.12 Cr | ₹31 Cr | ₹27 Cr |
Book Value | 213.99 | 190.89 | 180.31 | 310.59 | 327.03 |
Adjusted Book Value | 213.99 | 190.89 | 180.31 | 109.36 | 115.15 |
Compare Balance Sheet of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,222.6 Cr | -2.1% | -1.9% | 164.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,407.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,489.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
CIPLA | ₹117,443.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,338.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,244.9 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -2.1% |
-1.9% |
164.6% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses